Literature DB >> 28750112

Febrile Neutropenia.

Krish Patel, Howard Jack West.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28750112     DOI： 10.1001/jamaoncol.2017.1114

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  9 in total

1.  Induction of functional neutrophils from mouse fibroblasts by thymidine through enhancement of Tet3 activity.

Authors:  Buqing Ye; Liuliu Yang; Benyu Liu; Nian Liu; Dongdong Fan; Huimu Li; Lei Sun; Ying Du; Shuo Wang; Yong Tian; Zusen Fan
Journal:  Cell Mol Immunol       Date:  2022-03-17       Impact factor: 22.096

2.  Association between Breast Cancer Polygenic Risk Score and Chemotherapy-Induced Febrile Neutropenia: Null Results.

Authors:  Seeu Si Ong; Peh Joo Ho; Alexis Jiaying Khng; Elaine Hsuen Lim; Fuh Yong Wong; Benita Kiat-Tee Tan; Swee Ho Lim; Ern Yu Tan; Su-Ming Tan; Veronique Kiak Mien Tan; Rebecca Dent; Tira Jing Ying Tan; Joanne Ngeow; Preetha Madhukumar; Julie Liana Bte Hamzah; Yirong Sim; Geok Hoon Lim; Jinnie Siyan Pang; Veronica Siton Alcantara; Patrick Mun Yew Chan; Juliana Jia Chuan Chen; Sherwin Kuah; Jaime Chin Mui Seah; Shaik Ahmad Buhari; Siau Wei Tang; Celene Wei Qi Ng; Jingmei Li; Mikael Hartman
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.

Authors:  Vinay K Giri; Kristin G Kegerreis; Yi Ren; Lauren M Bohannon; Erica Lobaugh-Jin; Julia A Messina; Anita Matthews; Yvonne M Mowery; Elizabeth Sito; Martha Lassiter; Jennifer L Saullo; Sin-Ho Jung; Li Ma; Morris Greenberg; Tessa M Andermann; Marcel R M van den Brink; Jonathan U Peled; Antonio L C Gomes; Taewoong Choi; Cristina J Gasparetto; Mitchell E Horwitz; Gwynn D Long; Richard D Lopez; David A Rizzieri; Stefanie Sarantopoulos; Nelson J Chao; Deborah H Allen; Anthony D Sung
Journal:  Transplant Cell Ther       Date:  2021-01-07

4.  Home-Based Hematopoietic Cell Transplantation in the United States.

Authors:  Anthony D Sung; Vinay K Giri; Helen Tang; Krista Rowe Nichols; Meagan V Lew; Lauren Bohannon; Yi Ren; Sin-Ho Jung; Tara Dalton; Amy Bush; Jolien Van Opstal; Alexandra Artica; Julia Messina; Rebecca Shelby; Jennifer Frith; Martha Lassiter; Jill Burleson; Kari Leonard; Ashley S Potter; Taewoong Choi; Cristina J Gasparetto; Mitchell E Horwitz; Gwynn D Long; Richard D Lopez; Stefanie Sarantopoulos; Nelson J Chao
Journal:  Transplant Cell Ther       Date:  2022-01-20

5.  MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19.

Authors:  Valéria Bumiller-Bini; Camila de Freitas Oliveira-Toré; Tamyres Mingorance Carvalho; Gabriela Canalli Kretzschmar; Letícia Boslooper Gonçalves; Nina de Moura Alencar; Miguel Angelo Gasparetto Filho; Marcia Holsbach Beltrame; Angelica Beate Winter Boldt
Journal:  Genet Mol Biol       Date:  2021-03-17       Impact factor: 1.771

6.  Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia.

Authors:  Ying Wang; Zhichao Du; Yongdong Chen; Yugang Liu; Zhitang Yang
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

7.  Staphylococcus lugdunensis Urinary Tract Infection With Associated Neutropenic Fever.

Authors:  Rajanish Bobde; Joseph I Berger; Urma Jalil; Garine Kalaydjian
Journal:  Cureus       Date:  2022-01-19

8.  Validation of Risk of Chemotherapy-Induced Neutropenia: Experience from Oncology Hospital of Nepal.

Authors:  Ronash Shrestha; Safin Chapagai; Dip Kiran Shakya; Prashant Bista; Binaya Sapkota
Journal:  Cancer Manag Res       Date:  2020-05-20       Impact factor: 3.989

9.  Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis.

Authors:  Shao-Huan Lan; Shen-Peng Chang; Chih-Cheng Lai; Li-Chin Lu; Hung-Jen Tang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.